An open-label study was completed in 2016 in the UK to analyze the feasibility, safety and efficacy of psilocybin in treating individuals with unipolar treatment-resistant depression with promising outcomes; Even though the examine was little and associated only twelve clients, seven of People people achieved formal criteria for remission a person … Read More